Efficacy of PD1 blockade in cervical cancer has been linked to the presence of a CD8 + FoxP3 + CD25 + T-cell subset102 and an important limitation of our study is the inability to differentiate between CD8 + T-cell phenotypes. Here, CD8A is linked to cervical cancer.